Global Prenatal Testing Market

Report Code: MDS103A

Publish Date: May 2024

Publisher: BCC Publishing

Category: Medical Devices And Surgical

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.

Report Includes

  • 37 data tables and 52 additional tables
  • An overview of the current and future global markets for prenatal testing
  • Analyses of global market trends, with historical revenue data (sales figures) for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2028
  • Estimates of the current market size and revenue growth prospects, along with a market share analysis by technology and product types, application, end users and region
  • Discussion of the market opportunities and challenges, ongoing R&D efforts and regulatory scenarios
  • A look at emerging technologies related to prenatal testing
  • Overview of the sustainability trends and ESG developments, with emphasis on consumer attitudes, companies’ ESG rankings and their ESG practices
  • Insight into the competitive landscape, including company market shares, financials and revenues
  • Profiles of the leading players, including Illumina Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Natera Inc., and F. Hoffmann-La Roche Ltd.

Report Scope

The scope of the prenatal testing market is extensive and continually evolving, reflecting the dynamic landscape of technologies and methodologies employed to assess fetal health during pregnancy. Genetic testing plays a central role, encompassing a range of approaches from traditional invasive procedures, such as amniocentesis and chorionic villus sampling to modern noninvasive methods, such as noninvasive prenatal testing (NIPT). This market is characterized by its global reach, with varying levels of adoption and accessibility across different regions. The focus is predominantly on screening for genetic disorders, including chromosomal abnormalities and hereditary conditions. The rise of comprehensive testing strategies evaluating multiple biomarkers enhances diagnostic accuracy. The market is driven by increasing maternal age, heightened awareness of genetic disorders and technological advancements. Ongoing research and development (R&D) efforts continue to shape the scope of prenatal testing, with a strong emphasis on improving accuracy and accessibility and incorporating innovative diagnostic and screening procedures. It presents insights into current and future potential, drivers, challenges, opportunities, industry status, developments, market trends, geographical challenges and strategies (e.g., mergers, acquisitions, collaborations). The report informs all market players, potential entrants, government agencies and other interested parties. The report covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this helpful study.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $9.8 billion
Market size forecast $19.8 billion
Growth rate CAGR of 12.6% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Type, Technology, Application, End User, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Countries covered U.S., Canada, Germany, the U.K., France, Italy, Spain, China, India, Japan, the Middle East and South America
Key Market Drivers
  • Increasing cases of Down syndrome.
  • Rising maternal age.
  • Advancements in technology.
Companies studied
10X GENOMICS AGILENT TECHNOLOGIES INC.
BGI EUROFINS SCIENTIFIC
F. HOFFMANN-LA ROCHE LTD.ILLUMINA INC.
LABORATORY CORPORATION OF AMERICA HOLDINGS MEDICOVER GENETICS
NATERA INC. QIAGEN
QUEST DIAGNOSTICS INC.REVVITY INC.
THERMO FISHER SCIENTIFIC INC. YOURGENE HEALTH
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global prenatal testing market is projected to grow from $9.8 billion in 2022 to $19.8 billion in 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period.
  • Increase in down syndrome.
  • Increase in maternal age.
  • Advancements in technology.
  • Increase in genetic disorders.
This report segments the market based on type, technology, application, end-user, and region. The market is segmented into consumables and instruments based on the type. The market is segmented based on technology into noninvasive and invasive techniques. Noninvasive techniques are further segmented as non-invasive prenatal testing (NIPT), maternal serum screening, and ultrasound-based testing. Invasive techniques are further segmented as amniocentesis, chorionic villus sampling (CVS), and others. The market is segmented into neural tube defects, down syndrome, rare genetic disorders, and others based on application. Based on end-users, the market is segmented as diagnostic laboratories and hospitals. Based on region, the market is segmented as North America, Europe, Asia-Pacific, and Rest of the World.
Consumables will dominate the market by the end of 2028.
North America holds the highest share in the market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Prenatal Testing Market134Free
Chapter- 1: Executive Summary5Free
Chapter- 2: Market Overview5Free
Chapter- 3: Market Dynamics9Free
Chapter- 4: Emerging and Upcoming Technologies in the Market3Free
Chapter- 5: Market Segmentation Analysis44Free
Chapter- 6: Competitive Landscape7Free
Chapter- 7: ESG Development7Free
Chapter- 8: Appendix54Free

Related Reports

Global Market for Pain Management Drugs and Devices

Published - Dec 2023 | Publisher - BCC Publishing | Code - HLC026G

The global market for pain management drugs and devices is expected to increase from $84.6 billion in 2023 to $109.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2028.

Fetal Monitoring, Diagnostics and Predictive Tests

Published - Apr 2023 | Publisher - BCC Publishing | Code - HLC089C

The global market for fetal monitoring, diagnostics and predictive tests is estimated to increase from $10.4 billion in 2022 to reach $13.6 billion by 2027, at a compound annual growth rate (CAGR) of 5.6% from 2022 through 2027.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Apr 2022 | Publisher - BCC Publishing | Code - HLC239B

The global market for chronic disease management therapeutics anddevice technologies should grow from $391.8 billion in 2021 to $553.0 billion by 2026, at compound annual growth rate (CAGR) of 7.1% for the period of 2021-2026.

Recent Reports

Global Prenatal Testing Market

Published - May 2024 | Publisher - BCC Publishing | Code - MDS103A

The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.

Global Skin Allergy Testing Market

Published - May 2024 | Publisher - BCC Publishing | Code - MDS104A

The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.

Global Orthodontic and Orthopedic Market

Published - Apr 2024 | Publisher - Partha Sarathi Das | Code - MDS036B

The global market for orthodontic devices is expected to grow from $18.9 billion in 2023 and projected to reach $29.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023 to 2028.Report Includes

Global Medical Dynamometer Market

Published - Mar 2024 | Publisher - BCC Publishing | Code - MDS100A

The global market for medical dynamometers is estimated to increase from $547.5 million in 2023 to reach $780.1 million by 2028, at a compound annual growth rate (CAGR) of 7.3% from 2023 through 2028.

Global Insulin Pen Market

Published - Mar 2024 | Publisher - BCC Publishing | Code - MDS102A

This report examines the global insulin pen market. It includes a detailed analysis and prediction of commercially significant products such as reusable and disposable insulin pens. This report investigates global insulin pen market patterns and features between 2022–2028, offering valuable insights and forecasts.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Medical Robotics and Computer-assisted Surgery: The Global Market

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC036J

The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Sensors: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - IAS006P

The global market for sensors is estimated to increase from $179.7 billion in 2023 to reach $300.5 billion by 2029, at a compound annual growth rate (CAGR) of 8.9% from 2024 through 2029.

Water Filtration: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - MST080B

The global market for water filtration is expected to grow from $10.5 billion in 2024 and is projected to reach $19.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Prenatal Testing Market
Sample Report